PROTEOMICS INTERNATIONAL LABORATORIES LTD (PIQ)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 1 signal(s) for PIQ during the last 90 days, indicating Moderate trading activity

Latest PIQ Signals
08/05/2026	SELL
PIQ Share Price
Current Price	$0.200
52 Week High	$0.840
52 Week Low:	$0.100
Trading at (% of 52 Week High)	23.81%

Business Overview

Proteomics International Laboratories Ltd (ASX: PIQ) is a medical diagnostics company specializing in the development and commercialization of proteomics-based biomarker tests. The company focuses on improving disease detection and monitoring, particularly in diabetes and kidney disease. Its technologies aim to provide more accurate and early diagnosis to support better patient care.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for PROTEOMICS INTERNATIONAL LABORATORIES LTD (PIQ) is supported by moderate bearish signals, including potential valuation concerns and sector volatility. However, the confidence is tempered by limited negative catalysts and possible recovery prospects.

Latest  PROTEOMICS INTERNATIONAL LABORATORIES LTD(PIQ)   News